期刊文献+

长期抑酸维持治疗预防十二指肠溃疡复发的疗效及对血胃泌素的影响 被引量:1

Effects of long-term maintenance therapy on the prevention of recurrent duodenal ulcer and the level of serum gastrin
下载PDF
导出
摘要 目的 研究兰索拉唑治疗十二指肠溃疡和维持治疗预防溃疡复发的疗效 ,并探讨各疗程血清胃泌素水平的变化。方法 经胃镜证实的活动期十二指肠溃疡患者 90例 ,给予兰索拉唑 30mg ,qd× 4周 ,将溃疡愈合达瘢痕期的 6 7例患者随机分为两个治疗组。A组 :兰索拉唑 15mg ,qd ,维持 3个月 ;B组 :兰索拉唑 15mg ,qd ,维持 6个月。在治疗前 ,治疗 4周 ,维持治疗 3、6、9个月末分别复查胃镜 ,并检测血清胃泌素水平的变化。结果 治疗 4周后 ,溃疡愈合率 94 .4 % ( 85 / 90 )。A组和B组患者的溃疡半年累积复发率分别为 17.6 % ( 6 / 34)和 18.1% ( 6 / 33) ,2组间差异无显著性。在治疗 4周时 ,血清胃泌素水平基本达到一稳定水平 ,在维持治疗阶段无进一步升高 ,停药后 3个月基本恢复到基础水平。结论  3个月或 6个月低剂量兰索拉唑维持治疗可有效预防十二指肠溃疡复发 。 Objective To evaluate the effect of takeprin in preventing the recurrence of duodenal ulcer (DU) and investigate the varying level of serum gastrin. Methods 67 patients with DU, who had been treated with takeprin 30 mg qd for 4 weeks and had reached scar stage, were divided into two groups: in group A, the patients were maintained with takeprin 15 mg qd for 3 months, while in group B, the maintenance therapy was prolonged to 6 months. Gastroscopy was performed and serum gastrin was assayed before and after the 4-week treatment and 3, 6 and 9 months after the maintenance therapy. Results Ulcer healing rate was 94.4%(85/90) after the 4-week takeprin treatment. The semi-annual cumulative recurrence rate of DU was 17.6% (6/34) and 18.1% (6/33) in group A and group B respectively(P>0.05). The serum gastrin attained a relatively stable level after the 4-week treatment and was not further elevated in the course of maintenance therapy, and the serum gastrin returned to its basal level 3 months after the therapy was stopped. Conclusion Maintenance therapy of lower-dose takeprin for 3 or 6 months is effective for the prevention of recurrent DU, without causing further ascension of serum gastrin.
出处 《徐州医学院学报》 CAS 2003年第4期331-334,共4页 Acta Academiae Medicinae Xuzhou
关键词 抑酸药 十二指肠溃疡 复发 血清 胃泌素 胃镜 maintenance therapy duodenal ulcer recurrence/prevention serum gastrin
  • 相关文献

参考文献15

  • 1Penston J, Wormley KG. Efficacy and safety of long-term maintenance therapy of duodenal ulcersrs [ J ]. Scand J Gantroenterol, 1989,24(9): 1145-1152.
  • 2Earnest DL. Maintenance therapy in peptic ulcer disease[J]. Med Clin North Am, 1991,75(4): 1013-1038.
  • 3周丽雅,董秀云,成红艳,黄雪彪,褚雅贤,吕愈敏,丁士刚,夏志伟,顾芳,杨雪松,金珠,林三仁.质子系抑制剂维持治疗对十二指肠球部溃疡一年复发率的影响[J].胃肠病学,2001,6(1):43-45. 被引量:4
  • 4Sung JJ, Chung SC, Ling TK, etal. One-year follow-up of duoderal ulcers after 1-week triple therapy for helicobacter pylori[J]. Am J Gastroenterol, 1994,89(2): 199-202.
  • 5Mantzaris GJ, Hatzis A, Tamvakologos G, et al. Prospective ,randomizod, investigator-blind trail of helicobacter pylori infection treatment in patients with refractory duodenal ulcers: healing and long-terrm relapse rates[J]. Dig Dis Sci. 1993,38(6): 1132-1136.
  • 6Walan A, Bianchi-Porro G, Hentschel E, et al. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years [ J ].Sc and J Gastroenterol, 1987,22(4) :397-405.
  • 7陈寿坡.消化性溃疡病.见:潘国宗,曹世植主编.现代胃肠病学[M].北京:科学出版社,1996.903.
  • 8Konturek SJ. Gastric cytoprotection[J]. Scand J Gastroenterol, 1985,20(5) :543-553.
  • 9Robinson M, Lanza F, Avner D, et al. Effective maintenance treatment of reflux esophagitis with low-dose lansopraole: a randomized,double-blind, placebo-controlled trail[J]. Ann Intern Med, 1996,124(10) :859-867.
  • 10Koop H, Klein M, Amold R. Semm gastrin levels during long-term omeprazole treatment[J]. Aliment Pharmacol Ther, 1990,4(2): 131-138.

二级参考文献9

  • 1Penston J, Wormsley KG. Efficacy and safety oflong-term maintenance therapy of duodenal ulcers. Scand J Gastroenterol, 1989, 24: 1145~1152.
  • 2Bardhan KD, Hunter JO, Miller JP, Thomson AB,Graham DY, Russell RI, Sontag S, Hines C, Martin T, Gaussen L, et al. Antacid maintenance therapy in the prevention of duodenal ulcer relapse.Gut, 1989, 29: 1748~1754.
  • 3Russo A, Dattilo M. Bedtime administration of lansoprazole does not modify its greater efficacy vsranitidine in the acute and long-term treatment ofduodenal ulcer. Results from a multicentre, randomised, double blind clinical trial. Ital J Gastroenterol Hepatol, 1997, 29: 312~319.
  • 4Santander C, Gravalos RG, Gomez-Cedenilla A,Cantero J, Pajares JM. Antimicrobial therapy forHelicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer:prospective nonrandomized trial on 125 patients.Am J Gastroenterol, 1996, 91: 1549~ 1552.
  • 5Walan A, Bianchi-Porro G, Hentschel E, BardhanKD, Delattre M. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years.Scand J Gastroenterol, 1987, 22: 397~405.
  • 6Archimandritis A, Balatsos V, Delis V, Manika Z,Skandalis N. "Reappearance” of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study. J ClinGastroenterol, 1999, 28: 345~347.
  • 7Sauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori.Lancet, 1990, 1: 1233~1235.
  • 8McColl KE, el-Omar E, Gillen D, Banerjee S. Therole of Helicobacter pylori in the pathophysiologyof duodenal ulcer disease and gastric cancer. SeminGastrointest Dis, 1997, 8: 3~8.
  • 9周丽雅,林三仁,沈祖尧,钟尚志,金珠,黄雪彪,丁士刚,王立新,杨雪松,曹世植.洛赛克三联疗法对幽门螺杆菌根除及溃疡病发病影响的人群研究[J].中华消化杂志,1999,19(S1):9-11. 被引量:15

共引文献3

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部